insights_auto
Why is 4AB0 up 8.47%?
Dive Deeperchevron_right
4AB0:FRA
Abbvie CDR CAD Hedged
€25.60
arrow_upward
+8.47%(+2.00) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB0...
Open
€23.80
High
€25.60
Low
€23.60
Mkt. cap
499.53B
Avg. vol.
9.00
Volume
5.00
52-wk high
€25.60
52-wk low
€16.40
No. of employees
57K
Open
€23.80
High
€25.60
Low
€23.60
Mkt. cap
499.53B
Avg. vol.
9.00
Volume
5.00
52-wk high
€25.60
52-wk low
€16.40
No. of employees
57K
News stories
From web sources and news partners
Simply Wall Street
·
2 hours ago
AbbVie (ABBV) Posts Fresh Trial Wins, Is The Stock Fully Valued?
ad-hoc-news.de
·
8 hours ago
AbbVie stock: At 1.84 percent below its 52-week high, AbbVie stock trades at EUR 255.05
Yahoo Finance
·
9 hours ago
AbbVie vs. Bristol Myers: Is AbbVie’s Valuation Premium Worth Paying?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie CDR CAD Hedged
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com